P-グリコタンパク質の構造は,ポリスペシフィックな薬物結合のための分子基盤を明らかにします
Stephen G Aller1, Jodie Yu, Andrew Ward
1Department of Molecular Biology, Scripps Research Institute, 10550 North Torrey Pines Road, CB105, La Jolla, CA 92037, USA.
Science (New York, N.Y.)
|March 28, 2009
まとめ
P-glycoprotein (P-gp) の構造に関する洞察は,その薬物結合部位とエントリーポータルを明らかにします. これらのメカニズムを理解することは,新しい抗がん剤の開発と多剤耐性 (MDR) の克服に不可欠です.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- がん研究 がん研究
背景:
- P-glycoprotein (P-gp) は,がんにおける細胞解毒と多剤耐性 (MDR) に関するトランスポータータンパク質です.
- その基質の乱交性は,治療的介入のための詳細な構造的理解を必要とします.
研究 の 目的:
- P-グリコプロテインにおけるポリスペシフィックな薬物結合の構造的基礎を解明する.
- 異なる薬物結合部位を特定し,MDRにおけるその役割を理解する.
主な方法:
- X線結晶学を用いて,アポP-gpとP-gpの構造を,周期性ペプチド阻害剤との複合体として決定した.
- 内腔の大きさ,ヌクレオチド結合ドメインの分離,およびポータルアクセシビリティを含む構造的特徴の分析.
主要な成果:
- アポP-gp構造は,内部空洞と,核酸結合ドメインの重要な分離を明らかにした.
- 水性および芳香性相互作用に基づくステレオ選択性を持つ明確な薬物結合部位が特定されました.
- P-gp構造は,細胞質と脂質二重層へのオープンポータルを示し,薬物侵入経路を示した.
結論:
- 決定された構造は,P-gpの基板乱交性と薬物結合のための分子基盤を提供します.
- これらの発見は,新しい抗がん剤とMDR阻害剤の合理的な設計に不可欠です.
関連する概念動画
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
01:30Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
01:22Protein-Drug Binding: Determination Methods
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...